STARD8 Antikörper (AA 561-660) (FITC)
Kurzübersicht für STARD8 Antikörper (AA 561-660) (FITC) (ABIN763293)
Target
Alle STARD8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 561-660
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Cow,Pig,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human STARD8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- STARD8 (StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8))
-
Andere Bezeichnung
- STARD8
-
Hintergrund
-
Synonyms: Deleted in liver cancer 3, DLC3, StAR related lipid transfer protein 8, START domain containing protein 8, START GAP3, STAR8_HUMAN.
Background: This gene encodes a member of a subfamily of Rho GTPase activating proteins that contain a steroidogenic acute regulatory protein related lipid transfer domain. The encoded protein localizes to focal adhesions and may be involved in regulating cell morphology. This protein may also function as a tumor suppressor.
-
Gen-ID
- 9754
Target
-